At yesterday’s meeting, CT’s
Health Care Cabinet agreed to create four working groups to develop
recommendations and options to control drug spending in the state. We also
reviewed a report from CT’s APCD on the Top
50 Highest Total Cost Drugs in CT. The Cabinet has been taking a deep dive
into rising prescription drug costs for the last three months with
presentations from academics, drug company and industry representatives, DSS,
CT’s Attorney General, a Pharmacy Benefits Management company, wholesale drug
distribution, and pharmacists. The Cabinet considered a draft
summary document on the Cabinet’s activities to date, updates on
legislative proposals, further reading, and potential themes and areas for
further action. The group decided to create four working groups to develop
strategies – pricing, price transparency, research initiatives in other states,
and consumer/provider education. The subgroups will engage voices beyond the
Cabinet’s membership.
